Collectively, our findings establish the SRSF3/circSAMD4/CIRBP axis as a novel pathogenic pathway in CI-AKI and position circSAMD4 as a promising therapeutic target for CI-AKI. This evidence concerns the gene SRSF3 and acute kidney injury.